ProQR Therapeutics NV (PRQR)

6.600
-0.230(-3.37%)
After Hours
6.600
0.000(0.00%)
- Real-time Data
  • Volume:
    289,801
  • Bid/Ask:
    6.490/6.790
  • Day's Range:
    6.430 - 6.840

PRQR Overview

Prev. Close
6.83
Day's Range
6.43-6.84
Revenue
2.5M
Open
6.83
52 wk Range
3.4-9.44
EPS
-1.1
Volume
289,801
Market Cap
469.62M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
671,858
P/E Ratio
-
Beta
0.37
1-Year Change
66.25%
Shares Outstanding
71,154,571
Next Earnings Date
Mar 02, 2022
What is your sentiment on ProQR Therapeutics NV?
or
Market is currently closed. Voting is open during market hours.

ProQR Therapeutics NV Company Profile

Employees
0

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber’s congenital amaurosis 10 disease; QR-421a, which is in phase I/II stellar trial for usher syndrome type 2 and non-syndromic retinitis pigmentosa; QR-1123 that is in phase I/II aurora trial for the treatment of autosomal dominant retinitis pigmentosa; and QR-504a, which is in first clinical trial for the treatment of fuchs endothelial corneal dystrophy. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as ProQR Therapeutics VIII B.V. for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellBuy
SummaryStrong BuyNeutralStrong SellStrong SellNeutral
  • Guy let buy more nakd
    1
    • Rip who bought at 9 typical pump and dump
      4
      • Sell now pump amd dump
        4
        • 11 today
          0
          • Nope
            0
          • Nice tricking people dude
            0
        • amazing rise.
          0
          • target price up from 19 to 35 listed as a hold for now
            0
            • https://finance.yahoo.com/news/2-strong-buy-penny-stocks-153448116.html Strong Buy rating & analysts prediction $20
              0
              • Good moment for buy more
                0
                • ProQR, my best investment and they have just started! Go Dutchy Pharma!
                  0
                  • $PRQR Phase 1b top-line data due September 25, 2017 for Cystic Fibrosis
                    0
                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.